Hidrosmin
From Wikipedia, the free encyclopedia
|
Hidrosmin
|
|
| Systematic (IUPAC) name | |
| 5-(2-hydroxyethoxy)-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[ [(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one | |
| Identifiers | |
| CAS number | ? |
| ATC code | C05 |
| PubChem | |
| Chemical data | |
| Formula | C30H36O16 |
| Mol. mass | 652.59724 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Hidrosmin is a vasoprotective.
|
|||||||||||

